Allogene targets pivotal ALPHA3 data in April and extends cash runway into 2028 while prioritizing scalable CAR T programs

AI Briefing

• – Allogene reports positive ALPHA3 data in April, extends cash runway into 2028, prioritizes CAR T programs.
• – ALLO-329 June readout expected to be a key catalyst.
• – Company highlights key risks and priorities for the future.